Pane wikiwiki
Control peptide nanostructure design variables step by step: kaʻina, uku ʻupena, kūlana hui, counterions, nā lepili, a me ka maemae.
He aha ka mea i helu ʻia ma ke ʻano he Peptide Nanostructure Design Variable
ʻO kahi peptide nanostructure hoʻolālā hoʻololi kekahi ʻāpana e hoʻololi i ka mea kemika a i ʻole nā kūlana i hui ʻia ma lalo, a ke helu wale ʻia ʻo ia i hoʻomalu ʻia ke haʻi ʻoe me kēlā mau kūlana. ʻO ka hui ʻana iho ʻo ia ka hui kūʻokoʻa o nā molekole peptide i loko o nā hale i kauoha ʻia; ʻO kahi nanostructure ka hui hopena ma ka pālākiō nanometer. ʻO ka hoʻopili koʻikoʻi koʻikoʻi (CAC) ʻo ia ka paepae paepae i hoʻokumu ʻia ai nā hui, a he paepae maoli ia ma mua o ka hoʻokō: i loko o nā ʻōnaehana amyloid-type ka helu lua-nucleation e pili ana i ka neʻe ʻana o ka monomer a me ka ʻike fibril koʻikoʻi o ka nui. 10 nM, ʻoiai no ka semaglutide kahi koʻikoʻi koʻikoʻi o nā puʻupuʻu peptide e hoʻoulu i ka ulu autocatalytic i nā pule (Nā mea nano, 2022).

ʻEono mau ʻano hoʻololi i ka hapa nui o ka huikau i ka peptide self-assembly characterization: kaʻina, uku ʻupena, kūlana hui, ʻike kūʻē, lepili kemika, a me ka maemae. ʻAʻole nā counterions he footnote i kēlā papa inoa. Ke pale nei lākou i ka hoʻopiʻi peptide e ka ion-pairing me nā koena kumu a me ka termini, a ua hōʻike ʻia ʻo TFA e pili pū me ka pediocin PA-1, ke keʻakeʻa nei i ka nānā ʻana i ke kūkulu ʻana a me ka hoʻonui iki ʻana i ka maʻiʻo α-helical (Nā biomolele, 2025). Hiki ke hoʻololi ka ʻike counter-ion i ke ala hui, ʻaʻole wale ka hopena: Hoʻonui ʻia ka hoʻokumu ʻana o Aβ fibril me Cl⁻ me ka paʻakai TFA, a ʻike ʻia kahi ala waena α-helical me TFA⁻ wale nō (Nā lāʻau lapaʻau, 2020).
ʻO ia ke kumu e hiki ai i nā pepa ʻelua ke hōʻike i kahi "antimicrobial peptide nanofiber" a wehewehe i nā mea like ʻole..
Ki Takeaway: ʻO kahi hoʻololi hoʻolālā he mea hoʻololi wale nō ke hōʻike pū ʻia me nā kūlana i hoʻonohonoho ʻia.
No ke aha i kaohi ʻole ʻia ʻo Peptide Nanostructure Design Variables i haki i ka hoʻohālikelike haʻawina Cross-study
ʻAʻole paʻa ka hoʻohālikelike haʻawina keʻa no ka mea ʻaʻole paʻa mau nā ʻano, ʻaʻole no ka mea ʻaʻole hiki ke hana hou ʻia ka biology kumu. I ka noonoo ana, pH, ka wela a me ka ikaika ionic ma waena o nā hōʻike, Hiki i nā pepa ʻelua ke wehewehe i ke kaʻina like a ke ana mau nei i nā ʻōnaehana like ʻole. ʻO ka hopena kūpono, ʻo ka ʻokoʻa morphology i hoʻopili ʻia i ka hoʻolālā kaʻina e hōʻike paha i kahi buffer i ʻōlelo ʻole ʻia a i ʻole ka manaʻo hana ʻē aʻe..
Hiki ke hōʻike ʻia ke āpau ma mua o ka hypothetical. ʻO kahi loiloi e hōʻike ana i nā kūlana i koi ʻia a haʻalele iā lākou i ka papa inoa o ka manaʻo, pH, ka mahana a me ka ikaika ionic e like me nā kūlana hoʻokolohua pono, a laila hōʻike i kāna Aib oligopeptide, pyrenyl-pentapeptide a me nā ʻōnaehana hihia LB-film me ka ʻole o lākou. ʻAʻohe ʻano loiloi ʻōnaehana e helu ana i ka manawa i loaʻa ai kēia, no laila e mālama i kēia ma ke ʻano he hōʻike hōʻike ʻana, ʻaʻole i ana ʻia.
He kaʻina hana ka hoʻoponopono: E mālama i kēlā me kēia hoʻololi hoʻolālā ma ke ʻano he ʻāpana i hoʻopaʻa ʻia me kahi waiwai i ʻōlelo ʻia a me kahi ʻano hana ʻole, ʻo ia ka mea i kuhikuhi ʻia e nā ʻanuʻu ma lalo nei.
Ma mua o kou hoʻomaka ʻana: Nā mea e pono ai no kahi Panel Peptide Hoʻohālikelike

Hoʻohālikelike ʻia kahi panel inā hoʻokomo kēlā me kēia pūʻulu iā ia ma ke ʻano he mea kemika kikoʻī piha, ʻaʻole he kaula leka, me ka maemae, nuipa i hoʻopaʻa ʻia, counterion a i ʻole ke ʻano paʻakai a me ka ʻike i hoʻopaʻa ʻia me ke kaʻina (Hoʻomaʻamaʻa hōʻike kaʻina peptide). E hōʻuluʻulu i kēlā palapala ma mua o ka synthesis mua, ʻaʻole ma hope o ka hoʻāʻo hope.
ʻO kāu mea e pono ai:
-
Nā mea hana a me ke komo ʻana: RP-HPLC me kahi kolamu i kākau ʻia a me ka gradient; LC-MS no ka hōʻoia nui; dichroism pōʻai no ka heluhelu ʻana i ke kūkulu lua; hoʻopuehu māmā ikaika a i ʻole SAXS no ka puʻunaue nui; Loaʻa iā TEM a i ʻole AFM no ka morphology.
-
Reagents a me nā kūlana: counterion-exchange resin a i ʻole ka paʻakai o ke ʻano i manaʻo ʻia, me nā kūlana kuhikuhi no ka maʻemaʻe a me ka calibration nuipaʻa.
-
ʻIke i manaʻo ʻia: solid-phase peptide synthesis terminology a me ka hana maʻamau biophysical. Inā he mea hou ʻoe i ke kaʻina hana, e hana ma o ka peptide hoʻohuihui ponoʻī kumu mua.
-
Manawa: ma kahi o ʻelua a ʻehā pule no kēlā me kēia panel, hoʻomalu ʻia e ka synthesis a me ka hoʻomaʻemaʻe orthogonal hōʻoia.
-
Nā lawelawe Ka pilikia: waena a hiki i mua.
Hōʻike kumu. ʻO ka ʻO ke alakaʻi alakaʻi EMA e mana i Iune 2026 uhi i ka hana synthetic-peptide, hōʻailona, nā kikoʻī a me ka mana analytical, a ke manaʻo nei ia e hōʻike ʻia nā hopena hōʻike ma kahi counter-ion-free, kumu anhydrous. ʻO kēlā hui ka mea e hoʻohālikelike ai ka peptide antimicrobial a me ka hōʻoia analytical i nā labs, no laila e aʻo mai ka hoʻomaka.
Kūikawā: nā paepae haumia i ʻōlelo pinepine ʻia ma ke ʻano he hōʻike >0.1%, hoʻomaopopo >0.5% a kūpono >1.0% he mau helu hana wale nō. E hōʻoia iā lākou e kūʻē i ke alakaʻi PDF ma mua o kou kākau ʻana iā lākou i kahi kikoʻī.
ʻanuʻu 1: Wehewehe i ke Kaʻina ma ke ʻano he Hui Kemika, ʻAʻole kahi kaula leka
I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi moʻolelo kūkulu piha i hiki i ka mea heluhelu ʻelua ke hana hou i ka mole mai ia mea wale nō. ʻAʻole kēlā moʻolelo ʻo ke kaula kaʻina leka hoʻokahi. Haʻalele ia i kēlā me kēia hoʻololi e hoʻololi i ka nuipa, uku, a i ʻole ke ʻano hui pū, ʻo ia ke kumu e hiki ai i nā labs ʻelua ke hōʻike i ka "sequence" like a loaʻa i nā nanostructure ʻokoʻa.
Kākau i ka moʻolelo ma ka ʻōlelo N→C a hoʻokaʻaʻike i kēlā me kēia me kēia me ka maopopo:
-
Kaʻikala. Hōʻike i ke ʻano (poo-a-huelo, kaulahao ʻaoʻao-a-ʻaoʻao, disulfide) a me nā kūlana hoʻopaʻa pololei.
-
Hoʻopaʻa paʻa. Hāʻawi i nā kūlana stapling a me ka mea hoʻohui kemika, ʻaʻole wale "stapled".
-
Nā kūlana D-koena. E papa inoa i kēlā me kēia ma ka helu kūlana.
-
Lipidation. E inoa i ka ʻike lipid a me ka pūnaewele hoʻopili.
-
Nā pāpale kuʻina. E hoʻopaʻa i ka acetylation N-terminal (Ac-) a me C-terminal amidation (-NH2) kahi e noho nei.
-
ʻIke pūʻulu. Hoʻohui i ka maʻemaʻe, nuipa i hoʻopaʻa ʻia, ʻano kūʻē a paʻakai paha, a me ka peptide maʻiʻo no ka nui kikoʻī.
E mālama i kēia hohonu hōʻike ma ke ʻano he manaʻo hōʻike i hoʻopaʻa ʻia mai ka hui maʻamau, ʻaʻole ma ke ʻano he maʻamau i paʻi ʻia. ʻO ka ʻaha kūkā ʻo ia ka N→C peptide sequence notation i wehewehe ʻia i loko o nā mea kuhikuhi e like me ka Bionity peptide sequence entry., a ʻo nā mea ʻike pūʻulu e hahai i ka loina like: Hoʻohālikelike ʻia ke kūkulu ʻana ke hele pū kona mau ʻano i ana ʻia.
Hoʻohuihui Peptide Hooia: e hāʻawi i ka moʻolelo i kahi hoa hana i ʻike ʻole i ka noi synthesis. Inā hiki iā lākou ke kaha kiʻi i ka hui kemika piha, me kēlā me kēia hoʻololi a me kona kūlana, pau ka mooolelo. Inā pono lākou e nīnau i ke ʻano o ka "cyclized" ma aneʻi, ʻaʻole ia.
No ke kōkua: ʻO ka moʻolelo kūkulu ka ʻāpana o ka hoʻohālikelike. Inā ʻokoʻa nā moʻolelo ʻelua i ka hohonu o ka wehewehe, ua huikau ka hoohalike ana mamua o ka holo ana o kekahi hoao ana.
ʻanuʻu 2: E hōʻike i ka uku ʻupena ma ka pH Assay, ʻAʻole ka uku inoa
I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi kumukūʻai uku ʻupena i hōʻike ʻia ma kahi inoa ʻO nā Peptides Synthetic ʻano pH a me ka paʻakai, ʻaʻole kahi helu i kope ʻia mai kahi helu helu.
ʻO ka uku ʻupena he pH-pili, waiwai pale-pale, no laila, ʻaʻole i hoʻololi i ka hoʻolālā ʻana ka inoa "+8".. Noho pū ʻo Charge ma kahi ʻāpana kūʻai aku ma mua o ka pōmaikaʻi monotonic. Ma hoʻokahi moʻo V13K, e hoʻonui ana i ka uku ʻupena mai +8 i +9 ua hui pū ʻia me ka piʻi ʻana o ka hana hemolytic ma mua o 32, me HC50 e hāʻule ana mai 250 µg/mL i lalo 7.8 µg/mL, a +8 hāʻawi i ke kaulike therapeutic maikaʻi loa i kēlā pūʻulu hoʻokahi (Nā hopena o ka uku ʻupena a me ka helu o nā koena i hoʻopaʻa ʻia, Biopolymers, 2008/2010). Aia ka uku ʻoi loa ma mua o ka piʻi ʻana o ka hemolysis.
Hooia: ʻO nā inoa moʻolelo pH a me ka paʻakai e pili ana i ka uku.
ʻanuʻu 3: Hoʻoponopono i nā Kūlana Hui Pū ʻIa a hōʻike i ka Concentration Hoʻohui Koʻikoʻi
I ka pau ʻana o kēia ʻanuʻu, loaʻa iā ʻoe kahi protocol hui i kākau ʻia e hōʻike ana i ka manaʻo, pH, ikaika ionic, a me ka mahana, a me ka hoʻopaʻa ʻana o ka hoʻohui koʻikoʻi (CAC) no kēlā me kēia kaʻina. Hoʻonohonoho ʻia ka Morphology e kēia mau kūlana, no laila, ʻo kahi kūlana i hōʻike ʻole ʻia he hana hiki ʻole ke hana hou ʻia, ʻaʻole i haʻalele iki.
ʻO ke kumu o nā kūlana i loko o ka papa hoʻololi ʻo ia ke hiki i nā counter-ions ke hoʻokele pono iā ia iho. A 2025 loiloi ma Nā biomolele e pili ana i nā hopena o nā counter-ions ma ka peptide structure a me nā hōʻike hana e hui pū ai nā peptides amphiphilic i ka ʻike ʻana i nā molekole i hoʻopiʻi ʻia a i ʻole nā counter-ions., ʻO nā peptides acidic e hana i nā nanofibers ma lalo o nā kūlana acidic a i ʻole ma o ka pilina electrostatic me nā counter-ions, a ʻo kēlā Ca²⁺, trifluoroacetate, a me ka waika formic ua hōʻike ʻia kēlā me kēia e hoʻoikaika i ka peptide a me ka hoʻokumu ʻana o ka dimer protein ma HPLC. Ma ka hana, ʻo ia hoʻi, ʻo ka paʻakai i loko o kāu buffer a me ka counter-ion i waiho ʻia mai ka hoʻomaʻemaʻe ʻana, ʻo ia nā mea hoʻololi hui. Hana ʻia ʻo Peptide
E hōʻike i ka CAC ma ke ʻano he ana me kāna ʻano, no ka mea, hōʻailona ia i ka hoʻopaʻa ʻana ma luna aʻe e lilo ai ka hui i ka hoʻoikaika ʻana ma mua o ke kaʻina. No ka wehewehe a me ka nui i hōʻike ʻia, e ʻike i ka ʻāpana taxonomy ma luna.
Hooia: E hāʻawi i ka protocol i kahi hoa hana i ʻike ʻole i kāu puke. Inā hiki iā lākou ke holo i ka ʻanuʻu hui me ka nīnau ʻole iā ʻoe i hoʻokahi nīnau, pau ka pauku.
ʻanuʻu 4: E mālama i ka Counterion Exchange ma ke ʻano he ʻanuʻu ʻole ʻoe e ana
I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi pae counterion koena ma kahi o kahi i manaʻo ʻia. Kakaʻikahi ka pau ʻana o ka hoʻololi kūʻē, ʻo ia ka mea e hoʻopiʻi ai i ka paʻakai ma ka lepili vial ma mua o ka hopena. A 2020 ka nānā ʻana i nā hopena counter-ion i nā peptides hōʻike i ka hapa nui o nā ala i paʻi ʻia a hiki i 98% hoʻololi ma hope o kekahi mau hana hou ʻana, a ʻo ka waika hydrochloric dissolution a me ka lyophilisation ala "ʻaʻole e hāʻawi i kahi wehe TFA piha a hoʻololi i nā chlorides.,” me nā meheu i ʻike ʻia (ʻO ke kuleana o nā Counter-Ions ma nā Peptides, 2020).
E mālama i kēlā koena ma ke ʻano he hoʻololi hoʻolālā i kona pono ponoʻī. E hōʻike i ka maʻiʻo counterion i ana ma ka ʻaoʻao o ke ʻano paʻakai āu e koi nei, me ka hoʻohana ʻana i ke ʻano like a me ka pūʻulu like āu i hoʻouna ai i ka assay.
Hooia: ʻike ʻia ka pae counterion koena i kāu mau moʻolelo me ke ʻano paʻakai, ʻaʻole ma ke ʻano he footnote iā ia.
ʻanuʻu 5: E koho a hōʻoia i ka lepili ma mua o ka hilinaʻi ʻana i kekahi heluhelu i hoʻopaʻa ʻia

Hiki i ka fluorophore ke hoʻololi i ka ʻawaʻawa i ana ʻia me ka hoʻololi ʻole i ka spectrum CD. I loko o kahi papa peptide hana membrane, conjugation i ka hydrophobic a i ʻole nā fluorophores i hoʻopiʻi maikaʻi ʻia (RhB, Q570, TF3) Ua hoʻonui nui ʻia ka hemolytic toxicity pili i ka peptide unlabeled, ʻoiai ua hāʻawi liʻiliʻi ka CF i hoʻopiʻi ʻole ʻia; circular dichroism ʻaʻole i hōʻike ʻia ka ʻokoʻa lua ma waena o nā ʻano lepili a me nā ʻano lepa ʻole, no laila i ʻike ʻole ʻia ka manaʻo i ka heluhelu ʻana (He aha ka nui o nā Fluorophores Bias i ka hana olaola o nā Peptides?, Bioeng Biotechnol i mua, 2020). ʻO ke kānāwai kūpono: mai hoʻohālikelike i ka hana i hōʻailona ʻia me ka hana ʻole ʻia mai kahi kūkulu ʻē aʻe. Holo i nā ʻano ʻelua mai ka pūʻulu hoʻokahi, a mālama i nā hopena lepili peptide ma ka hui ʻana ma ke ʻano he loli āu e ana, ʻaʻole he mea hoʻolaha kūʻokoʻa āu e manaʻo ai.
No ke kōkua: Inā loaʻa mai nā ʻano lepili a me ka lepili ʻole mai nā ʻāpana ʻokoʻa, ʻAʻole hiki iā ʻoe ke hoʻokaʻawale i ka hōʻailona hōʻailona mai nā ʻano like ʻole. E hoʻokaʻawale i hoʻokahi ʻāpana synthesis ma mua o ka hui ʻana.
ʻanuʻu 6: E hoʻokumu i ka maʻemaʻe ma kahi kumu Net-Content a hōʻoia iā ia ma ke ʻano Orthogonally

I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi helu maʻemaʻe hiki iā ʻoe ke pale i ka loiloi, ʻaʻole he pākēneka ʻāpana wale nō mai hoʻokahi chromatogram.
ʻO ka pākēneka o ka ʻāpana HPLC ʻaʻole he ʻike peptide net. ʻO ka pākēneka o ka ʻāpana e helu ana i nā mea e hoʻoheheʻe ʻia e UV i kāu puka aniani; ʻaʻohe mea e pili ana i nā counterions, wai koena, a i ʻole ka hakina nui ʻo ia kāu kaʻina. ʻO ke kiʻi pinepine ʻia o "95% maʻemaʻe e HPLC akā wale nō 70% peptide by mass" e holo nei ma ke ʻano he kumu kūʻai aku me ka ʻole o ka waihona kumu mua ma hope o ia, no laila e mālama iā ia ma ke ʻano he hana kūpono ma mua o ka helu helu. ʻO ka helu pale ʻia ʻo ka ʻikepili peptide net: ka hopena ho'āʻo i hōʻike ʻia ma kahi counter-ion-free, kumu anhydrous, ʻO ia ke kumu e koi ai ka European Medicines Agency no ka hōʻike ʻana i ka peptide assay i kāna alakaʻi i nā peptides synthetic..
ʻIke ʻia kēlā me kēia ala i kahi ʻāpana ʻokoʻa o ka hāpana, ʻo ia ke kumu i lawa ʻole ai kekahi:
-
LC-MS paʻa-nuipaʻa hōʻoia i ka molecular mass o nā ʻano nui a hōʻailona i nā hoʻololi nui, akā ʻaʻole hiki iā ia ke ʻike i kahi isomer co-eluting o ka nui like.
-
LC-MS/MS peptide palapala palapala localizes sequence-level defects like deamidation, ʻoki ʻana, a i ʻole kahi hoʻohui i hala, a ʻo ia wale nō ke ala maʻamau e haʻi iā ʻoe i hea hewa kekahi kaʻina.
-
Ka nānā ʻana i ka ʻakika amino hāʻawi i ka ratio haku mele a, me kahi maʻamau calibrated, he waiwai maʻiʻo piha, ʻaʻole hiki iā ia ke hoʻokaʻawale i ke kaʻina isomer.
-
Hoʻokaʻawale Orthogonal (hoʻololi ion a i ʻole electrophoresis capillary hale kūʻai me RP-HPLC) hoʻoholo i nā mea i hui pū ʻia ma lalo o hoʻokahi mīkini.
-
ʻO ka dichroism pōʻai a me ka FTIR hōʻike i ke kūkulu lua, aole maemae, a me DLS a i ʻole TEM/AFM hōʻike mokuʻāina, ʻaʻole ʻike kemika. E hoʻohana iā lākou e hōʻoia i ke ʻano o ke kūkulu ʻana e like me ka mea i hoʻolālā ʻia, ʻaʻole loa he hōʻike maʻemaʻe.
No ka maʻemaʻe peptide antimicrobial a me ka hōʻoia analytical, ʻO ke kānāwai kūpono, ʻo ka helu helu ʻupena a me hoʻokahi hōʻoia orthogonal ka liʻiliʻi loa.. Hoʻokahi ʻāpana RP-HPLC ma 220 ʻo ka nm he wahi hoʻomaka, ʻaʻole kahi kikoʻī hoʻokuʻu.
Inā makemake ʻia ka mea no ka hoʻohana injectable, ʻelua mau palena compendial e pili ana ma luna o ka maʻemaʻe kemika. ʻO nā palena ʻāpana i loko USP <788> e hoʻonoho i nā paepae hoʻopololei ʻaʻole ʻoi aku ma mua o 6,000 nā ʻāpana o kēlā me kēia pahu ma 10 µm a nui aʻe a 600 no ka pahu ma 25 µm a ʻoi aku paha no ka hoʻoheheʻe liʻiliʻi, hoopaa ana i 25 ʻāpana/mL a 3 particles/mL no ka nui-volume injections. Hoʻokaʻawale ʻia ʻo Endotoxin e ka helu K/M endotoxin palena ma USP <85>, kahi o EL = K/M a me K 5 USP-EU/kg no nā ala ʻē aʻe ma waho o intrathecal a 0.2 USP-EU/kg no intrathecal. Hoʻopaʻa ʻia nā mea ʻelua me ka nui a me ke ala, no laila aia lākou i ka kikoʻī ma mua o ka hoʻokuʻu ʻia ʻana o ka pūʻulu mua, ʻaʻole ma hope o ka nānā ʻole ʻana i ka sterility.
Hooia: hōʻike i kahi helu maʻiʻo upena ma kahi counter-ion-free, kumu anhydrous, inoa i ke ʻano orthogonal i hōʻoia ʻia, a e haʻi i nā palena hoʻopaʻi e pili ana inā makemake ʻia ka mea no ka injection.
Nā hewa maʻamau e hōʻalo ai
ʻO ka hāʻule pinepine ma kēia kahua ʻo ka hōʻike ʻana i kahi uku nominal a me kahi maʻemaʻe nominal me he mea lā ua ana ʻia nā mea ʻelua.. Loaʻa i kēlā me kēia kuhi hewa ma lalo nei kahi ʻano hemahema i kākau ʻia a me kahi hoʻoponopono kikoʻī.
ʻO ka haʻi ʻana i ka uku nominal ma mua o ka pH i ʻōlelo ʻia. Heluhelu ʻia ka uku nominal mai ke kaʻina; ʻO ka uku i ʻike maoli ʻia e ka assay ma muli o nā koina pKa kaulahao ʻaoʻao a me ka pH buffer. ʻO ka hoʻoponopono e helu a hōʻike i ka uku ʻupena ma ka pH assay, me ka mea paahana a me kona mana i kapaia.
Ke manaʻo nei ua pau ka hoʻololi counterion. Hiki ke hoʻomau ka Trifluoroacetate mai ka hoʻomaʻemaʻe RP-HPLC ma o ka lyophilization, ka hoʻololi ʻana i ka nuipa a me ka hana ʻike. ʻO ka hoʻoponopono ʻana ʻo ke ana ʻana i nā maʻiʻo counterion koena ma mua o ka manaʻo ua pau ka hoʻololi.
Ka hoʻohālikelike ʻana i nā mea i hoʻopaʻa ʻia a me ka lepili ʻole ʻia ma nā pūʻulu like ʻole. Hoʻololi ka fluorophore a i ʻole affinity tag i ka hydrophobicity a me ka ʻano hui pū, no laila, ʻaʻole like ka hui kemika me kona makua. ʻO ka hoʻoponopono e hoʻohālikelike i loko o hoʻokahi pūʻulu a i ʻole e haʻi i ka lepili ma ke ʻano he ʻokoʻa.
Ka mālama ʻana i ka pākēneka o ka wahi RP-HPLC ma ke ʻano he peptide content. Helu chromophore ka pākēneka ʻāpana, ʻaʻole ka nui o ka peptide, no laila e hoʻonui i ka ʻike i ka wā e kūʻē ai, wai, a i ʻole nā huahana ʻokiʻoki i loaʻa. ʻO ka hoʻoponopono ʻana ʻo ka hoʻokumu ʻana i ka maʻemaʻe peptide antimicrobial a me ka hōʻoia analytical ma ke kumu ʻupena a nānā iā ia me ka orthogonally.
Haalele ana i ka noonoo, pH, ikaika ionic, a me ka mahana mai ka protocol hui. Hoʻonohonoho kēia mau ʻāpana ʻehā i ke ala hui, a ʻo ka waiho ʻana i kekahi o lākou me ka ʻole i hōʻike ʻia e hana i ka nanostructure i hōʻike ʻole ʻia. ʻO ka hoʻoponopono e hōʻike i nā ʻehā no kēlā me kēia hoʻomākaukau.
⚠️ ʻŌlelo Aʻo: ʻO kahi waiwai i lawe ʻia i loko o ka papa hoʻohālikelike e lilo i mea hoʻololi hoʻopunipuni hoʻopunipuni.
Pehea ka holomua
Inā ua hahai ʻia ke kaʻina hana, ʻO kēlā me kēia kūkulu i loko o ka panel e lawe i kahi moʻolelo kaʻina, he uku ʻupena i hōʻike ʻia ma kahi pH assay i wehewehe ʻia, he ʻano paʻakai i ʻōlelo ʻia me ke koena counterion, he protocol hui i palapala ʻia me ka manaʻo koʻikoʻi o ka hōʻuluʻulu ʻana kahi e kūpono ai ka ʻaha, he paʻa hoʻopaʻa inoa ʻole ʻia, a me kahi helu hoʻomaʻemaʻe ʻupena i hoʻopaʻa ʻia e kahi ʻano orthogonal. ʻO kēlā mau huahana ʻeono ka mea e pale ai ka panel: hiki i kekahi mea loiloi ke ʻimi i kahi ʻano i hōʻike ʻia i nā kūlana i hoʻopuka ai ma mua o kahi paʻamau i ʻōlelo ʻole ʻia.
ʻO ka pahuhopu e hoʻolōʻihi i ka panel i kahi ʻano counterion ʻelua o ke kaʻina like a hoʻāʻo i ka neʻe ʻana o ke ala hui.. ʻO ka Aβ chloride versus trifluoroacetate hoʻohālikelike ʻo ia ka hihia kuhikuhi no ke kumu kūpono ke nīnau ʻana i kēlā nīnau., ʻoiai ʻo ka counterion wale nō i hoʻoneʻe i ka ʻano hui i ʻike ʻia.
Nīnau pinepine
He aha ka mea e hoʻomalu ai i ka hana ʻana o kahi peptide i nā fibers a i ʻole vesicles?
ʻO ke kaulike ma waena o ke ʻano hydrophobic a me ka hydrophilic ma ke kaʻina, ka uku ʻupena ma ka pH assay, a me nā kūlana hui āu i kau ai ma Steps 2 a 3 ʻO nā ʻano like ʻole e pili mau ana i ka morphology i nānā ʻia. Hōʻike nā hōʻike e hiki i nā loli liʻiliʻi i kekahi o lākou ke neʻe i kahi peptide ma waena o nā morphologies, ʻo ia ke kumu e hiki ai ke hōʻike ʻia ke kaʻina like me nā hopena like ʻole ma nā labs. ʻO ka pane kūpono ʻaʻohe mea hoʻololi hoʻokahi e hoʻomalu i ka hopena, no laila e hōʻike pū iā lākou a pau ma mua o ka hoʻohui ʻana i ka hopena i hoʻokahi.
Hiki iaʻu ke hoʻololi i kahi kemika lepili ʻē aʻe inā ʻaʻole i loaʻa ka mea aʻu i hoʻolālā ai?
Hiki iā ʻoe, akā inā ʻoe e holo hou i ka hōʻoia ma Step 5 no ka mea pani, no ka mea, ʻo ka hoʻopaʻa inoa ʻana ma ka hui ʻana he chemistry-specific a ʻaʻole i hoʻololi ʻia kahi heluhelu i hoʻopaʻa ʻia no kekahi lepili i kekahi.. Hiki i ka lepili i ʻae ʻia no hoʻokahi peptide ke hoʻopilikia i ka hui ʻana iho a i ʻole ka heluhelu biological no kekahi. E mālama i ka hoʻololi ʻana ma ke ʻano he hoʻololi hoʻolālā hou ma mua o ka hoʻololi like-for-like.
He aha kaʻu e hana ai inā kū ka counterion exchange ma lalo o ka pahuhopu?
E hōʻoia i ka hale kūʻai maoli ma mua o ka hoʻololi ʻana i kekahi mea: ana i ke koena counterion maʻiʻo ma ka upena maʻiʻo, e like me ka Step 6, ma mua o ka hoʻomaopopo ʻana i ka hoʻopau ʻana mai ka helu o nā pōʻai hoʻololi. Inā ʻaʻole i hoʻokō maoli ʻia ka pahuhopu, hōʻike i ka waiwai i loaʻa a me nā kūlana hoʻololi ma kahi o ka waiwai i manaʻo ʻia. ʻO kahi hui i hoʻololi ʻole ʻia he mokuʻāina hiki ke hōʻike ʻia, ʻaʻole he hoʻokolohua hāʻule.
Pehea ka hopena o ka manawa EMA i ka hana e holo nei?
ʻAʻole i mana ke alakaʻi, no laila, ʻaʻole i hoʻopau ʻia nā haʻawina e hana nei, akā, ʻo ka haumia a me ke ʻano o nā mea i manaʻo ʻia ʻo ia ke kuhikuhi o ka huakaʻi. Kahi e hiki ai iā ʻoe ke hoʻohana i ka ʻupena-maʻiʻo a me nā hana hōʻoia orthogonal i ka Step 6 i kēia manawa, liʻiliʻi ke kumu kūʻai a hoʻemi i ka hana hou ma hope. E mālama i nā paepae o kēia manawa ma ke ʻano he manawa kūpono a hiki i ka hōʻoia ʻana o ke kikokikona alakaʻi hope.
Pau nā paepae haumia?
ʻAʻole. ʻO nā paepae i kuhikuhi ʻia i loko o kēia alakaʻi he mea kūʻokoʻa a pono e hōʻoia ʻia e kūʻē i ke alakaʻi PDF ma mua o kou hilinaʻi ʻana iā lākou no ka hoʻoholo hoʻokuʻu.. A hiki i kēlā hōʻoia, e hoʻohana iā lākou ma ke ʻano he pahuhopu hoʻolālā ma mua o ka palena hoʻokō, a palapala i ka mana āu i hana ai.
Nā ʻanuʻu aʻe
Loaʻa iā ʻoe kahi papa inoa e hoʻohuli i kahi kaʻina peptide i kahi kūkulu like: he mea kemika i hoomaopopoia, ka uku ma ka pH assay, nā kūlana hui hoʻomalu me ka hōʻike koʻikoʻi koʻikoʻi koʻikoʻi, maʻiʻo counterion ana, he lepili i hooiaioia, a me ka hoʻomaʻemaʻe i hoʻopaʻa ʻia ma ke kumu net-content. ʻO nā kūkulu hoʻohālikelike ka mea e hiki ai i nā koi hoʻohālikelike like, a ʻo kēlā aʻo ʻana ke kumu o ka hana hilinaʻi ma nā peptide nanostrategies e kūʻē i ka maʻi kūʻē i ka lāʻau. E pili ana
Loaʻa i ka MOL Changes kahi hoihoi pāʻoihana i nā kūlana maikaʻi peptide, a me kāna pūʻolo analytical palapala i nā ʻāpana a kēia alakaʻi e noi ai iā ʻoe e hōʻike. Inā makemake ʻoe e ʻike pehea i hoʻonohonoho ʻia ai kēlā palapala, e nānā i ka pūʻolo analytical no ke kaʻina hōʻike.
ʻO kēlā me kēia unuhi lapaʻau a lapaʻau paha i kūkākūkā ʻia ma ʻaneʻi he pōʻaiapili preclinical. E kamaʻilio i kahi ʻoihana kūpono ma mua o ka hoʻohana ʻana i kēia mau hana a i ʻole nā mea i ʻike ʻia i ka hana maʻi.
Nānā ʻia e [inoa], Ph.D., Kemika Analytical.
Kaʻina aʻe: E ʻike pehea i kākau ʻia ai ka maikaʻi o ka peptide. E noʻonoʻo i ka pūʻolo analytical, a laila palapala ʻāina i kēlā me kēia palapala hōʻoia o ka mahina ʻana i nā ʻāpana i nā Steps 2, 4, a 6 o keia alakai.

